A delicate redox balance between iron and heme oxygenase-1 as an essential biological feature of endometriosis.


Journal

Archives of medical research
ISSN: 1873-5487
Titre abrégé: Arch Med Res
Pays: United States
ID NLM: 9312706

Informations de publication

Date de publication:
08 2021
Historique:
received: 02 01 2021
revised: 08 03 2021
accepted: 25 03 2021
pubmed: 18 4 2021
medline: 15 12 2021
entrez: 17 4 2021
Statut: ppublish

Résumé

Recent studies have focused on the role of oxidative stress, which may be implicated in the development, progression, and pathophysiology of endometriosis. The aim of this study is to investigate the redox balance of endometriosis by simultaneously measuring iron-related compounds (total iron, heme iron, free iron, oxyhemoglobin [oxyHb], methemoglobin [metHb] and 8-hydroxy-2-deoxy guanosine [8-OHdG]) and antioxidants (bilirubin, heme oxygenase-1 [HO-1] and total antioxidant capacity [TAC]). This study includes 236 histopathologically confirmed cases (178 cases of endometriosis and 58 cases of non-endometriosis). Cyst fluid samples were collected from patients admitted to the Department of Gynecology, Nara Medical University, Kashihara, Japan, for surgery. Age at diagnosis (p <0.001), the maximum diameter of the cyst (p <0.001) and CA125 levels (p <0.001) differed significantly between the two groups. Total iron, heme iron, free iron, metHb, and oxyHb were markedly higher in endometriosis compared to non-endometriosis. Bilirubin, HO-1 and TAC were significantly higher in endometriosis patients compared with those from non-endometriosis patients. In endometriosis, total iron showed a positive correlation with HO-1 (r, 0.518, p = 0.001), but there were no antioxidants that correlated with iron in non-endometriosis. Iron and HO-1 did not correlate with age or tumor size. HO-1 may regulate the delicate balance of iron-induced oxidative stress in endometriotic cyst fluid.

Sections du résumé

BACKGROUND
Recent studies have focused on the role of oxidative stress, which may be implicated in the development, progression, and pathophysiology of endometriosis.
AIM OF THE STUDY
The aim of this study is to investigate the redox balance of endometriosis by simultaneously measuring iron-related compounds (total iron, heme iron, free iron, oxyhemoglobin [oxyHb], methemoglobin [metHb] and 8-hydroxy-2-deoxy guanosine [8-OHdG]) and antioxidants (bilirubin, heme oxygenase-1 [HO-1] and total antioxidant capacity [TAC]).
METHODS
This study includes 236 histopathologically confirmed cases (178 cases of endometriosis and 58 cases of non-endometriosis). Cyst fluid samples were collected from patients admitted to the Department of Gynecology, Nara Medical University, Kashihara, Japan, for surgery.
RESULTS
Age at diagnosis (p <0.001), the maximum diameter of the cyst (p <0.001) and CA125 levels (p <0.001) differed significantly between the two groups. Total iron, heme iron, free iron, metHb, and oxyHb were markedly higher in endometriosis compared to non-endometriosis. Bilirubin, HO-1 and TAC were significantly higher in endometriosis patients compared with those from non-endometriosis patients. In endometriosis, total iron showed a positive correlation with HO-1 (r, 0.518, p = 0.001), but there were no antioxidants that correlated with iron in non-endometriosis. Iron and HO-1 did not correlate with age or tumor size.
CONCLUSIONS
HO-1 may regulate the delicate balance of iron-induced oxidative stress in endometriotic cyst fluid.

Identifiants

pubmed: 33863580
pii: S0188-4409(21)00077-1
doi: 10.1016/j.arcmed.2021.03.006
pii:
doi:

Substances chimiques

Iron E1UOL152H7
HMOX1 protein, human EC 1.14.14.18
Heme Oxygenase-1 EC 1.14.14.18

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

641-647

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Shogo Imanaka (S)

Department of Obstetrics and Gynecology, Nara Medical University, Kashihara, Nara, Japan; Ms.Clinic MayOne, Kashihara, Nara, Japan.

Yuki Yamada (Y)

Department of Obstetrics and Gynecology, Nara Medical University, Kashihara, Nara, Japan.

Naoki Kawahara (N)

Department of Obstetrics and Gynecology, Nara Medical University, Kashihara, Nara, Japan.

Hiroshi Kobayashi (H)

Department of Obstetrics and Gynecology, Nara Medical University, Kashihara, Nara, Japan; Ms.Clinic MayOne, Kashihara, Nara, Japan. Electronic address: hirokoba@naramed-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH